跳至主要内容
临床试验/NCT01184911
NCT01184911撤回4 期

Assessment of the Efficacy of Sulphadoxine-Pyrimethamine for Intermittent Preventive Treatment of Malaria in Pregnancy in Uganda

University of California, San Francisco1 个研究点 分布在 1 个国家开始时间: 2010年10月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
撤回
试验地点
1
主要终点
Parasite clearance

研究概览

简要总结

The effectiveness of sulfadoxine-pyrimethamine (SP) as intermittent preventive treatment in pregnancy in malaria-endemic areas the effectiveness and efficacy of SP may be compromised by increased SP resistance. This study will evaluate the efficacy of SP by giving SP to asymptomatic parasitemic pregnant women and following them to determine the rates of parasite clearance.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Prevention
盲法
None

入排标准

性别
Female
接受健康志愿者

入选标准

  • 16-26 weeks gestation based on LMP or ultrasound or fundal height
  • Axillary temperature <37.5 degrees C
  • Informed consent
  • HIV status known and negative
  • Blood smear positive for falciparum malaria

排除标准

  • History of hypersensitivity reaction to SP or components of SP
  • Axillary temperature ≥37.5 degrees C
  • History of receipt of antimalarials or antibiotics with antimalarial activity* in the past month
  • Residence > 30 km from the ANC clinic or unwillingness to return for follow-up visits
  • Hemoglobin level < 5 gm/dL
  • These medications include all antimalarials, rifampin, doxycycline, clindamycin, tetracycline, erythromycin, azithromycin, chloramphenicol.

研究组 & 干预措施

SP

Experimental

Asymptomatic parasitemic pregnant women who receive the standard dose of sulfadoxine-pyrimethamine for prevention of placental malaria

干预措施: Sulfadoxine-pyrimethamine (Drug)

结局指标

主要结局

Parasite clearance

时间窗: 42 days

Clearance of parasites in pregnant women with asymptomatic parasitemia after administration of SP

次要结局

未报告次要终点

研究者

申办方类型
Other

研究点 (1)

Loading locations...

相似试验